Advertisement
B&K Corporation Limited

B&K Corporation Limited (2396.HK) Stock Overview

Explore B&K Corporation Limited’s financial performance, market position, analyst ratings, and future outlook.

2396.HKHKSE
HealthcareBiotechnology
HK$4.18
HK$0.32(7.11%)
Hong Kong Market opens in 39h 45m
Advertisement

B&K Corporation Limited (2396.HK)

Meyka AI Score

Z

Key Financials

Market Cap347M
P/E RatioN/A
EPS (TTM)$-2.41
ROEN/A
Fundamental Analysis

AI Price Forecasts

1 Month$3.26
3 Months$0.00
1 Year Target$0.00

2396.HK Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of B&K Corporation Limited (2396.HK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 34.22, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of N/A and a market capitalization of 347M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-7.11%
5-Day Change
-5.00%
1-Month Change
-20.83%
3-Month Change
-41.94%
6-Month Change
-80.25%
Year-to-Date (YTD) Change
-74.15%
1-Year Change
-84.52%
3-Year Change
-84.52%
5-Year Change
-84.52%
All-Time (Max) Change
-84.52%

Contact Information

NaN
Building 1, Qingdao, SD, NaN

Company Facts

1,000 Employees
IPO DateDec 21, 2025
CountryCN
Actively Trading

Frequently Asked Questions